ENDRA Life Sciences EBITDA 2017-2025 | NDRA
ENDRA Life Sciences ebitda from 2017 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
ENDRA Life Sciences Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-11 |
| 2023 | $-10 |
| 2022 | $-13 |
| 2021 | $-11 |
| 2020 | $-11 |
| 2019 | $-8 |
| 2018 | $-8 |
| 2017 | $-4 |
| 2016 | $-1 |
|
ENDRA Life Sciences Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-1 |
| 2025-06-30 | $-1 |
| 2025-03-31 | $-1 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-3 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-3 |
| 2021-09-30 | $-3 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-2 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.005B | $0.000B |
| ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.087B | 25.32 |
| Intuitive Surgical (ISRG) | United States | $195.983B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $53.421B | 53.05 |
| Edwards Lifesciences (EW) | United States | $49.175B | 32.97 |
| Alcon (ALC) | Switzerland | $37.787B | 25.54 |
| IQVIA Holdings (IQV) | United States | $36.805B | 20.52 |
| Mettler-Toledo (MTD) | United States | $28.374B | 33.20 |
| STERIS (STE) | Ireland | $25.225B | 26.04 |
| DexCom (DXCM) | United States | $22.812B | 31.45 |
| Waters (WAT) | United States | $22.503B | 29.76 |
| Hologic (HOLX) | United States | $16.490B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.802B | 0.00 |
| Globus Medical (GMED) | United States | $11.194B | 23.49 |
| Penumbra (PEN) | United States | $10.907B | 76.72 |
| Masimo (MASI) | United States | $7.898B | 25.31 |
| Sysmex ADR (SSMXY) | Japan | $6.137B | 19.50 |
| Glaukos (GKOS) | United States | $5.077B | 0.00 |
| Teleflex (TFX) | United States | $4.590B | 7.31 |
| TransMedics (TMDX) | United States | $3.875B | 45.91 |
| Veracyte (VCYT) | United States | $3.105B | 35.39 |
| Alphatec Holdings (ATEC) | United States | $2.952B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.929B | 15.82 |
| Integer Holdings (ITGR) | United States | $2.351B | 11.04 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| Nihon Kohden (NHNKY) | Japan | $1.794B | 15.66 |
| Elekta AB (EKTAY) | Sweden | $1.692B | 16.39 |
| PROCEPT BioRobotics (PRCT) | United States | $1.625B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.243B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.196B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.087B | 51.77 |
| OPKO Health (OPK) | United States | $0.975B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.932B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.914B | 4.95 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.524B | 30.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.516B | 10.30 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.474B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.409B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.396B | 10.92 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Semler Scientific (SMLR) | United States | $0.304B | 2.29 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.184B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.182B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.118B | 0.00 |
| Neuronetics (STIM) | United States | $0.113B | 0.00 |
| Accuray (ARAY) | United States | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.091B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.07 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |